Real-World Evidence
Everything on Aqrab tagged Real-World Evidence — grouped into one landing page so readers can go deeper by problem family instead of bouncing around the archive blind.
Delayed Entry in Survival Analysis: Why Nobody Is at Risk Before They Enter
A practical guide to left truncation in clinical survival analysis. Align the origin, entry time, event time, and risk set before interpreting Kaplan–Meier curves or Cox models from prevalent cohorts.
Target Trial Emulation Cannot Randomize Clinical Judgment: A Pertussis Study Audit
A practical target-trial emulation audit using an infant pertussis study. Check clinical-judgment confounding, propensity-score overlap, endpoint timing, sparse outcomes, and claim strength.
Vaccine Effectiveness Without Matching: Why Calendar Time Comes Before Pairing
A practical guide to calendar time in vaccine-effectiveness studies. Learn how changing uptake and infection hazards alter risk sets, estimands, and target-trial conclusions.
Specification Curve Analysis: When One Model Hides a Vibration of Effects
A practical guide to specification curve analysis in clinical research. Learn how to define reasonable analyses, separate robustness checks from estimand changes, and audit results that move across defensible choices.
Comparator Selection in Observational Studies: Why the Control Group Changes the Question
A practical guide to comparator selection in observational studies. Learn how active comparators change the estimand, confounding structure, and interpretation of real-world evidence.
Time-Varying Treatment Dose: When Recovery Gets Counted as the Intervention
A practical guide to time-varying treatment dose in clinical research. Learn why accumulated exposure can encode recovery, how baseline matching misses treatment-confounder feedback, and what reviewers should demand from longitudinal dose-response claims.
Test-Negative Designs: When the Control Group Is Chosen by the Testing Door
A practical guide to auditing test-negative vaccine-effectiveness studies. Check the clinical case definition, testing pathway, control illness, calendar time, and estimand before treating 1 minus an odds ratio as protection.
Treatment-Timing Effects: When “Earlier Is Better” Needs a Fair Clock
A practical guide to auditing earlier-is-better claims in observational studies. Test time zero, treatment strategies, evolving clinical decisions, positivity, and timing curves before reading a treatment gradient as biological.
Broad Benefit Patterns in Observational Studies: When One Treatment Appears to Prevent Everything
A practical guide to auditing outcome-wide benefit patterns in real-world evidence. Learn what clean negative controls can and cannot prove, how shared bias can move many endpoints together, and when a broad pattern should remain hypothesis-generating.
Discordant Clinical Endpoints: When One Study Produces Two Treatment Winners
A practical guide to discordant clinical endpoints using a matched MS registry study. Audit endpoint hierarchy, estimand alignment, ascertainment, and absolute effects before turning a mixed outcome dashboard into one treatment winner.
How to Audit a Target-Trial Emulation: Four Decisions Behind One Mortality Estimate
A practical target-trial emulation audit using a dialysis mortality study. Translate a day-91 landmark, sustained-treatment threshold, competing event, and center context into the question actually estimated.
Risk-Set Matching: Why the Comparison Group Must Follow the Clock
A practical risk-set matching guide for time-varying treatment. Learn why later-treated patients can be valid comparators now, how fixed exposure groups create timing bias, and what reviewers should demand.
Causal Readiness: When a Huge Linked Dataset Still Cannot Identify an Effect
A practical guide to causal readiness in linked health and administrative data. Learn why scale and propensity-score overlap are not enough when treatment, need, comparators, or outcomes are poorly measured.
Bayesian Borrowing: When Historical Data Starts Spending Credibility It Did Not Earn
A practical guide to Bayesian borrowing for clinical researchers. Covers exchangeability, commensurate priors, historical controls, calendar-time drift, and what reviewers should demand before trusting extra certainty borrowed from earlier data.
Depletion of Susceptibles: When Early Harm Vanishes Because the Vulnerable Patients Are Already Gone
A practical guide to depletion of susceptibles for clinical researchers. Covers front-loaded harm, survivor selection, why later follow-up can falsely reassure, and what reviewers should demand before trusting a calming hazard curve.
Nested Case-Control Design: When Cheap Control Sampling Still Has to Respect Event Time
A practical guide to nested case-control design for clinical researchers. Covers incidence-density sampling, risk-set control selection, how it differs from case-cohort design, and what reviewers should demand before trusting the result.
Benchmarking Target Trial Emulation: When a Trial Copy Never Checks It Can Reproduce the Known Answer
A practical guide to benchmarking target trial emulation for clinical researchers. Covers why benchmark replication matters, what it cannot prove, and what reviewers should demand before trusting an observational extension.
Weak Instruments and Physician Preference IVs: When Treatment Movement Is Not Yet Causal Credibility
A practical guide to weak instruments and physician-preference IVs for clinical researchers. Covers first-stage weakness, exclusion leakage, local interpretation, and what reviewers should demand before trusting an IV claim.
ROBINS-I: When an Observational Effect Estimate Is Too Biased to Grade Casually
A practical guide to ROBINS-I for clinical researchers. Covers the seven bias domains, why confounding and time zero usually dominate, how overall judgments are formed, and what reviewers should demand before trusting non-randomized evidence.
Case-Cohort Design: When Measuring Everyone Is the Wrong Expense
A practical guide to case-cohort design for clinical researchers. Covers when a random subcohort is more honest than measuring everyone, how it differs from nested case-control sampling, and what reviewers should demand before trusting the result.
Overlap Weighting: When the Average Treatment Effect Stops Being the Honest Question
A practical guide to overlap weighting for clinical researchers. Covers why overlap weighting can stabilize observational comparisons, how it changes the target population, and what reviewers should demand before trusting a trimmed-looking causal claim.
Augmented Inverse Probability Weighting: When “Doubly Robust” Starts Hiding Which Model Failed
A practical guide to augmented inverse probability weighting for clinical researchers. Covers what AIPW estimates, why doubly robust does not mean low-risk, and what reviewers should demand before trusting the label.
Case-Time-Control Design: When Case-Crossover Starts Confusing Time Trends with Treatment Effects
A practical guide to the case-time-control design for clinical researchers. Covers exposure-time trends, referent sampling, protopathic bias, and what reviewers should demand before trusting a self-matched trigger analysis.
Channeling Bias: When the Newer Treatment Inherits the Easier Patients
A practical guide to channeling bias for clinical researchers. Covers preferential prescribing, formulary-era drift, specialist selection, and what reviewers should demand before trusting observational comparisons of newer therapies.
Consistency and Treatment Versioning: When One Exposure Label Hides Several Different Interventions
A practical guide to consistency and treatment versioning for clinical researchers. Covers when an exposure is too vaguely defined for causal interpretation, how hidden intervention versions distort transportability, and what reviewers should demand instead.
Confounding by Contraindication: When the Untreated Group Is Too Fragile for the Therapy
A practical guide to confounding by contraindication for clinical researchers. Covers how treatment avoidance in high-risk patients can make therapies look safer or more effective than they are, and what reviewers should demand instead.
Time Zero Alignment: When Your Cohort Starts Counting Before Treatment Does
A practical guide to time zero alignment for clinical researchers. Covers eligibility, treatment assignment, delayed initiation, immortal time, and what reviewers should demand before trusting a real-world effect estimate.
Informative Visit Processes: When Who Shows Up Starts Writing the Results
A practical guide to informative visit processes for clinical researchers. Covers endogenous follow-up, unequal observation schedules, visit-triggered outcome capture, inverse-intensity thinking, and what reviewers should demand before trusting longitudinal real-world results.
External Control Arms: When a Comparison Group Arrives from Another Universe
A practical guide to external control arms for clinical researchers. Covers historical and real-world comparators, design drift, prognostic imbalance, endpoint mismatch, and what reviewers should demand before trusting single-arm success stories.
Stochastic Interventions: When “Treat Everyone” Is Not the Policy Question
A practical guide to stochastic interventions for clinical researchers. Covers when deterministic treatment rules become unrealistic, how probability-shift interventions preserve positivity, and what reviewers should demand before trusting policy-effect claims.
Baseline Covariate Windows: When “Pre-Treatment” Variables Arrive Fashionably Late
A practical guide to baseline covariate windows for clinical researchers. Covers lookback periods, stale severity measures, same-day contamination, confounding capture, and what reviewers should demand before trusting “adjusted” observational results.
Calendar Time Confounding: When Secular Trends Pretend Your Intervention Worked
A practical guide to calendar time confounding for clinical researchers. Covers secular trends, treatment diffusion, concurrent comparators, and what reviewers should demand before trusting real-world benefit that may just reflect a later era.
Explore more topics
These are ranked by how often they appear alongside Real-World Evidence, so the next click is more likely to be useful than random.